Waverley Pharma Inc. (TSXV:WAVE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0250
+0.0100 (66.67%)
Mar 9, 2026, 2:36 PM EST
150.00%
Market Cap 810.00K
Revenue (ttm) 1.51M
Net Income (ttm) -367.11K
Shares Out 54.00M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 11,539
Open 0.0200
Previous Close 0.0150
Day's Range 0.0200 - 0.0250
52-Week Range 0.0100 - 0.0400
Beta 1.38
RSI 42.92
Earnings Date Apr 28, 2026

About Waverley Pharma

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol WAVE
Full Company Profile

Financial Performance

In 2024, Waverley Pharma's revenue was 475,373, an increase of 15.36% compared to the previous year's 412,090. Losses were -947,077, -57.42% less than in 2023.

Financial Statements

News

There is no news available yet.